




版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)
文檔簡介
Chapter21:
Antimicrobial
MedicationsImportantPoint:Ifyouarehavingtroubleunderstandinglecturematerial:Tryreadingyourtextbeforeattendinglectures.AntimicrobialChemotherapeutics“Theprognosisforpeoplewithcommondiseasessuchasbacterialpneumoniaandseverestaphylococcalinfectionwasgrimbeforethediscoveryandwidespreadavailabilityofpenicillininthe1940s.”“Physicianswereabletoidentifythecauseofthedisease,buttheyweregenerallyunabletorecommendtreatmentsotherthanbedrest.”EarlyhistoryofAntimicrobialChemotherapeuticAgents:1910:Salvarsan(anarseniccompound)byPaulEhlrich1928:Penicillin(amoldproduct--firstantibioticdiscovered)byAlexanderFleming1932:Sulfanilamide(sulfadrug)byGerhardDomagk1941:PurificationofPenicillinbyErnstChainandHowardFloreypost-WWII:WidespreadavailabilityPenicillinGAntibioticDiscoveryItiseasytoidentifyantibiotic-producingmicroorganism,thehardpartisfindingantibioticsthataresufficientlySelectivelyToxic.Post-microbemodifiedantibioticsarecalledSemisyntheticantibiotics.SelectiveToxicitymeansthattheagentismoretoxicagainstbacteriathanagainst,e.g.,humans.AntimicrobalChemotherapyTermsDistinguishingAntibioticsAntibiotics(aswellassyntheticantimicrobials)differintermsof…Theorganismtheyareorwereisolatedfrom.Theirchemicalstructure.Their(chemo)Therapeuticindex.Bacteriostasisversusbacteriostatic.Theirspectrumofactivity.Their
pharmacokinetics
(tissuedistribution,metabolism,andexcretion).Theirsiteofactioninbacterialcells.Interactionwithotherchemotherapeutics.Potentialforevolutiontoresistance.Mechanismoftoxicitytothehost.Cost.DistinguishingAntibioticsAntibiotics(aswellassyntheticantimicrobials)differintermsof…Theorganismtheyareorwereisolatedfrom.Theirchemicalstructure.Their(chemo)Therapeuticindex.Bacteriostasisversusbacteriostatic.Theirspectrumofactivity.Their
pharmacokinetics
(tissuedistribution,metabolism,andexcretion).Theirsiteofactioninbacterialcells.Interactionwithotherchemotherapeutics.Potentialforevolutiontoresistance.Mechanismoftoxicitytothehost.Cost.AntibioticsSourcesDistinguishingAntibioticsAntibiotics(aswellassyntheticantimicrobials)differintermsof…Theorganismtheyareorwereisolatedfrom.Theirchemicalstructure.Their(chemo)Therapeuticindex.Bacteriostasisversusbacteriostatic.Theirspectrumofactivity.Their
pharmacokinetics
(tissuedistribution,metabolism,andexcretion).Theirsiteofactioninbacterialcells.Interactionwithotherchemotherapeutics.Potentialforevolutiontoresistance.Mechanismoftoxicitytothehost.Cost.FamilyTreeofPenicillinsAntibioticsarechemotherapeuticantimicrobialsthatareisolatedfrommicroorganisms.Compare:“Syntheticdrug.”SomePenicillinDerivativesMethicillin-InducedLysisVancomycinCell-WallSynthesisInhibitorsDistinguishingAntibioticsAntibiotics(aswellassyntheticantimicrobials)differintermsof…Theorganismtheyareorwereisolatedfrom.Theirchemicalstructure.Their(chemo)Therapeuticindex.Bacteriostasisversusbacteriostatic.Theirspectrumofactivity.Their
pharmacokinetics
(tissuedistribution,metabolism,andexcretion).Theirsiteofactioninbacterialcells.Interactionwithotherchemotherapeutics.Potentialforevolutiontoresistance.Mechanismoftoxicitytothehost.Cost.TherapeuticIndexItisrelativelytrivialtoidentifyantibiotics.Thetrickistoidentifyantibioticsthatareselectivelytoxic—harmingthepathogenbutnotthehost.WeemployaconceptcalledtheTherapeuticIndexasameasureofthedegreeofselectivetoxicity.Thetherapeuticindexistheratioofthetoxicdosagetothetherapeuticdosage.Thatis,(Lowestdosetoxictopatient)(Dosenormallyusedfortherapy).Thegreatertheratio(ordifference)ofthesetwonumbers,theeasieritistofindadosagethatkillsthepathogenwithoutharmingthehost.TherapeuticIndexTherapeuticIndexTherapeuticIndex=ToxicDose/TherapeuticDoseDrugDosage(perKgBodyWeight)ToxicTherapeuticToxicTherapeuticToxicTherapeuticSmallRatio(dangerous)ModerateRatioHighRatio(safe)Mostdesirable.DistinguishingAntibioticsAntibiotics(aswellassyntheticantimicrobials)differintermsof…Theorganismtheyareorwereisolatedfrom.Theirchemicalstructure.Their(chemo)Therapeuticindex.Bacteriostaticversusbactericidal.Theirspectrumofactivity.Their
pharmacokinetics
(tissuedistribution,metabolism,andexcretion).Theirsiteofactioninbacterialcells.Interactionwithotherchemotherapeutics.Potentialforevolutiontoresistance.Mechanismoftoxicitytothehost.Cost.Bactericidalagentsoutrightkillbacteria.Bacteriostaticagentsinhibitgrowthbutdon’tkill.Theyrelyonbodydefensestocleartheinfection.Removalofagentresultsinreturnofgrowthofanyremainingbacteria.Bactericidalagentsarepreferableparticularlyifthebodyotherwisehastroubleclearingthebacteria.DistinguishingAntibioticsAntibiotics(aswellassyntheticantimicrobials)differintermsof…Theorganismtheyareorwereisolatedfrom.Theirchemicalstructure.Their(chemo)Therapeuticindex.Bacteriostasisversusbacteriostatic.Theirspectrumofactivity.Their
pharmacokinetics
(tissuedistribution,metabolism,andexcretion).Theirsiteofactioninbacterialcells.Interactionwithotherchemotherapeutics.Potentialforevolutiontoresistance.Mechanismoftoxicitytothehost.Cost.SpectrumofActivityNarrow-SpectrumAntimicrobialWide-SpectrumAntimicrobialSpectrumofActivityWide-SpectrumAntimicrobialBroad-spectrumantibioticsareusefulifonemustbegintreatmentbeforeidentifyingeitherapathogenoritsantibioticsusceptibility.However,broad-spectrumantibioticsaremorelikelytodestroynormalflora,resultinginsuperinfections.
DistinguishingAntibioticsAntibiotics(aswellassyntheticantimicrobials)differintermsof…Theorganismtheyareorwereisolatedfrom.Theirchemicalstructure.Their(chemo)Therapeuticindex.Bacteriostasisversusbacteriostatic.Theirspectrumofactivity.Their
pharmacokinetics
(tissuedistribution,metabolism,andexcretion).Theirsiteofactioninbacterialcells.Interactionwithotherchemotherapeutics.Potentialforevolutiontoresistance.Mechanismoftoxicitytothehost.Cost.Penetrationoftheantibiotictoinfectedtissuesiskindofimportant,andantibioticsdifferinwhereandtowhatdegreetheypenetrate.Anitibioticsdifferintermsofhowthebodymodifiesordestroysthem,e.g.,livervs.kidneys.Ultimately,antibioticsarenotretainedwithinthebodyindefinitely,andthedosageandrateofadministrationallowsabalanceofuptakeandexcretion.Concentrationsatthesiteofactionshouldremainhighthroughoutthetreatmentperiod,thoughnotsohighthatthehostispoisoned.FluctuationofAntibioticLevelswithTimeTimeofingestionofdose#3.DistinguishingAntibioticsAntibiotics(aswellassyntheticantimicrobials)differintermsof…Theorganismtheyareorwereisolatedfrom.Theirchemicalstructure.Their(chemo)Therapeuticindex.Bacteriostasisversusbacteriostatic.Theirspectrumofactivity.Their
pharmacokinetics
(tissuedistribution,metabolism,andexcretion).Theirsiteofactioninbacterialcells.Interactionwithotherchemotherapeutics.Potentialforevolutiontoresistance.Mechanismoftoxicitytothehost.Cost.FindingTargetsDrug-FindingAbilityasFunctionofHost-PathogenSimilarityBacteriaFungi,Helminths,Viruses,#BiochemicalDifferencesfromMammalianHostNumberDrugTargetsorDrugswithHighChemotherapeuticIndexToo-FewGenes&sharehostMetabolismTooBiochemicallysimilarasfellowEukaryotesBasicallytheyareUs!DifferentdomainfromUs!TargetsofAntibacterialDrugsTargetsofAntibacterialDrugsYes,doknowthefiveindicatedsitesofaction.No,donotmemorizethespecificantibioticsfromthisfigure.RibosomalTargetsTetracyclinesTetracyclineDistinguishingAntibioticsAntibiotics(aswellassyntheticantimicrobials)differintermsof…Theorganismtheyareorwereisolatedfrom.Theirchemicalstructure.Their(chemo)Therapeuticindex.Bacteriostasisversusbacteriostatic.Theirspectrumofactivity.Their
pharmacokinetics
(tissuedistribution,metabolism,andexcretion).Theirsiteofactioninbacterialcells.Interactionwithotherchemotherapeutics.Potentialforevolutiontoresistance.Mechanismoftoxicitytothehost.Cost.CombinationofDrugsForantibiotics“A”and“B”usedincombination:Actualkillingrate=A+BAdditiveActualkillingrate>A+BSynergisticActualkillingrate<A+BAntagonisticTypicallybacteriostaticagentsareantagonistictobactericidalagents.Bacteriocidalagentscanbesynergistic(thinkofthelatterasoneantibioticweakensmorebacteriathanitkills,makingthenot-killedbacteriamoresusceptibletoadditionalinsultbythesecondantibiotic).Additivemeansthatthetwo(ormore)antibioticsneitherhindernorhelpeachother’sabilitytokill.Alsorelevanttoratesofmutationtoresistance.CombinationofDrugsForantibiotics“A”and“B”usedincombination:Actualkillingrate=A+BAdditiveActualkillingrate>A+BSynergisticActualkillingrate<A+BAntagonisticTypicallybacteriostaticagentsareantagonistictobactericidalagents.Bacteriocidalagentscanbesynergistic(thinkofthelatterasoneantibioticweakensmorebacteriathanitkills,makingthenot-killedbacteriamoresusceptibletoadditionalinsultbythesecondantibiotic).Additivemeansthatthetwo(ormore)antibioticsneitherhindernorhelpeachother’sabilitytokill.Alsorelevanttoratesofmutationtoresistance.Synergisticmeansgreaterthanthesumoftheparts.Antagonisticmeanslessthanthesumoftheparts.MutationtoResistanceThenumberofresistantbacteriaisdependentontherateofmutationtoresistance.RationalforCombiningDrugsWhatyouwantisarateofmutationtomultipledrugresistancethatislessthanthanthereciprocalofthepathogenpopulationsize(andthensomeaccountingforlackofenvironmentalhomogeneity).ConsequenceofNotCombiningIfthiswerecancerthaneach“bump”wouldrepresenttheendofremission.Inahomogeneouspopulationthiswouldbethelastcancercell/virus/pathogenalive.ConsequenceofNotCombiningSo,hence,multi-druganti-cancerchemotherapyorcombinationtherapyagainstHIVorTB.NotMaintainingCourseObviouslythisisnotwhatyouwanttohappen.DistinguishingAntibioticsAntibiotics(aswellassyntheticantimicrobials)differintermsof…Theorganismtheyareorwereisolatedfrom.Theirchemicalstructure.Their(chemo)Therapeuticindex.Bacteriostasisversusbacteriostatic.Theirspectrumofactivity.Theirpharmacokinetics
(tissuedistribution,metabolism,andexcretion).Theirsiteofactioninbacterialcells.Interactionwithotherchemotherapeutics.Potentialforevolutiontoresistance.Mechanismoftoxicitytothehost.Cost.AcquiredAntibioticResistanceInnateorIntrinsicResistancemeansthattheantibiotictargetssimplyaremissingfromabacterium,e.g.,lackofcellwall=penicillinresistance.Alternativelythereexistanumberofnon-intrinsic(acquired)mechanismsthatcanleadtoantibioticresistance.AcquiredAntibioticResistanceAcquiredresistancecanoccurbyalterationoftargetbychromosomalmutation.Oracquisitiononplasmidencodingresistancegenes.ResistanceinSimplerTerms…BABy-passAlteredtargetEffluxImpermeabilityInactivationChromosomalvs.RPlasmidEncodedBABy-passAlteredtargetEffluxImpermeabilityInactivationChromosomalmutationRplasmidRplasmidDistinguishingAntibioticsAntibiotics(aswellassyntheticantimicrobials)differintermsof…Theorganismtheyareorwereisolatedfrom.Theirchemicalstructure.Their(chemo)Therapeuticindex.Bacteriostasisversusbacteriostatic
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 印刷企業(yè)市場調(diào)研方法考核試卷
- 家庭裝飾畫框批發(fā)考核試卷
- 園藝陶瓷的公共空間裝飾效果考核試卷
- 印刷設(shè)備生產(chǎn)過程的智能化技術(shù)應(yīng)用案例考核試卷
- 圖書出租業(yè)務(wù)的服務(wù)標(biāo)準(zhǔn)化培訓(xùn)考核試卷
- 影視錄放設(shè)備的智能鏡頭切換考核試卷
- 暖氣施工合同范本
- 簽訂重大銷售合同范本
- 口腔消毒培訓(xùn)課件
- 電商行業(yè)產(chǎn)品描述免責(zé)協(xié)議承諾書
- EPC項目采購管理方案
- 旅游景區(qū)旅游安全風(fēng)險評估報告
- 門窗安裝工程投標(biāo)書范本(二)
- 追覓科技在線測評題
- 智鼎在線測評107題
- 病歷書寫規(guī)范與住院病歷質(zhì)量監(jiān)控管理制度
- 12詩詞四首《漁家傲-秋思》公開課一等獎創(chuàng)新教學(xué)設(shè)計 初中語文九年級下冊
- 金礦承包協(xié)議合同2024年
- 解讀國有企業(yè)管理人員處分條例(2024)課件(全文)
- 創(chuàng)新創(chuàng)業(yè)基礎(chǔ)-理論、案例與訓(xùn)練(大學(xué)生創(chuàng)新創(chuàng)業(yè)教育課程)全套教學(xué)課件
- TD/T 1072-2022 國土調(diào)查坡度分級圖制作技術(shù)規(guī)定(正式版)
評論
0/150
提交評論